Recent molecular studies have established a critical link between HS1BP3 and cancer malignancy, particularly within aggressive gastric and breast carcinomas. The HCLS1-Binding Protein 3 (HS1BP3) interacts directly with the SH3 domain of cortactin. This interaction promotes a malignant phenotype that facilitates tumor progression. Furthermore, clinical data indicate that high HS1BP3 expression correlates with significantly reduced survival for patients with gastric adenocarcinoma and triple-negative breast carcinoma (TNBC). Consequently, identifying these molecular markers could improve prognostic accuracy in clinical settings.

Mechanisms of HS1BP3 and Cancer Malignancy

Researchers mapped the interaction site to the third proline-rich region (PRR3.1) of HS1BP3. This specific region is essential for several oncogenic processes. Specifically, the interaction drives cancer cell proliferation and extracellular matrix degradation. Moreover, HS1BP3 regulates the secretion pathways that cancer cells use to invade surrounding tissues. In addition, the study found that HS1BP3 expression levels match the expression of the scaffold protein TKS5. Therefore, the HS1BP3-cortactin axis serves as a master regulator of the invasive machinery in these high-risk cancers.

Impact on TKS5 Localisation and Secretion

The study also highlights how mutations in the HS1BP3 PRR3.1 site alter cellular behavior. Specifically, these mutations cause the scaffold protein TKS5 to accumulate within multivesicular endosomes. This buildup suggests a failure in the normal secretion process, which paradoxically supports the aggressive nature of the tumor. Consequently, these findings provide a mechanical explanation for why HS1BP3 levels correlate so strongly with poor patient survival. Since TNBC and gastric cancers often lack targeted treatment options, these insights into endosomal trafficking offer a potential new therapeutic target.

Frequently Asked Questions

What is the clinical significance of HS1BP3 in oncology?

HS1BP3 serves as a biomarker for poor prognosis. High levels of this protein are associated with shorter survival times in gastric adenocarcinoma and triple-negative breast cancer patients due to increased cell invasion.

How does HS1BP3 interact with cortactin?

HS1BP3 binds to the SH3 domain of cortactin via its PRR3.1 region. This interaction is necessary for the cell's ability to degrade the extracellular matrix and proliferate rapidly.

Why is the localization of TKS5 important?

TKS5 is an invadopodia scaffold protein. When HS1BP3 is mutated or dysregulated, TKS5 accumulates in multivesicular endosomes, which disrupts normal secretion and modulates the cancer's malignant phenotype.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional clinical judgment. Refer to the latest local and national guidelines for clinical practice.

References

Løchen AA et al. Interaction of HS1BP3 with cortactin modulates TKS5 localisation, cell secretion and cancer malignancy. Mol Oncol. 2026 Apr 10. doi: 10.1002/1878-0261.70248. PMID: 41960636.